| Title | Current Opinion in Endocrinology, Diabetes and Obesity |
| Abbreviation | Curr. Opin. Endocrinol. Diabetes Obes. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Endocrinology (Q2); Endocrinology, Diabetes and Metabolism (Q2); Internal Medicine (Q2); Medicine (miscellaneous) (Q2); Nutrition and Dietetics (Q2) |
| h-index | 78 |
| Overall Rank/Ranking | 6551 |
| SCImago Journal Rank (SJR) | 0.746 |
| Impact Score | 2.84 |
| Publisher | Lippincott Williams and Wilkins Ltd. |
| Country | United States |
| ISSN | 1752296X, 17522978 |
| Best Quartile | Q2 |
| Coverage History | 2007-2022 |
Current Opinion in Endocrinology, Diabetes and Obesity is a journal covering the technologies/fields/categories related to Endocrinology (Q2); Endocrinology, Diabetes and Metabolism (Q2); Internal Medicine (Q2); Medicine (miscellaneous) (Q2); Nutrition and Dietetics (Q2). It is published by Lippincott Williams and Wilkins Ltd.. The overall rank of Current Opinion in Endocrinology, Diabetes and Obesity is 6551. According to SCImago Journal Rank (SJR), this journal is ranked 0.746. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 78. The best quartile for this journal is Q2.
The ISSN of Current Opinion in Endocrinology, Diabetes and Obesity journal is 1752296X, 17522978. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Opinion in Endocrinology, Diabetes and Obesity is cited by a total of 651 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Current Opinion in Endocrinology, Diabetes and Obesity is 2.84, which is computed in 2023 as per its definition. Current Opinion in Endocrinology, Diabetes and Obesity IF is decreased by a factor of 0.34 and approximate percentage change is -10.69% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Current Opinion in Endocrinology, Diabetes and Obesity is 2.84. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.84 |
| 2021 | 3.18 |
| 2020 | 2.75 |
| 2019 | 3.59 |
| 2018 | 3.42 |
| 2017 | 3.56 |
| 2016 | 4.15 |
| 2015 | 3.53 |
| 2014 | 3.55 |
Current Opinion in Endocrinology, Diabetes and Obesity has an h-index of 78. It means 78 articles of this journal have more than 78 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Current Opinion in Endocrinology, Diabetes and Obesity is 1752296X, 17522978. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Current Opinion in Endocrinology, Diabetes and Obesity is 6551. According to SCImago Journal Rank (SJR), this journal is ranked 0.746. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.746 |
| 2021 | 0.814 |
| 2020 | 1.199 |
| 2019 | 1.075 |
| 2018 | 1.182 |
| 2017 | 1.467 |
| 2016 | 1.412 |
| 2015 | 1.383 |
| 2014 | 1.346 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 6551 |
| 2021 | 5581 |
| 2020 | 3313 |
| 2019 | 3865 |
| 2018 | 3401 |
| 2017 | 2393 |
| 2016 | 2620 |
| 2015 | 2735 |
| 2014 | 2743 |
Current Opinion in Endocrinology, Diabetes and Obesity is published by Lippincott Williams and Wilkins Ltd.. It's publishing house is located in United States. Coverage history of this journal is as following: 2007-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Current Opinion in Endocrinology, Diabetes and Obesity is Curr. Opin. Endocrinol. Diabetes Obes.. This abbreviation ('Curr. Opin. Endocrinol. Diabetes Obes.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Endocrinology (Q2); Endocrinology, Diabetes and Metabolism (Q2); Internal Medicine (Q2); Medicine (miscellaneous) (Q2); Nutrition and Dietetics (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Current Opinion in Endocrinology, Diabetes and Obesity latest impact IF is 2.84. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 4.15 (2016) and 2.75 (2020), respectively, in the last 9 years. Moreover, its average IS is 3.4 in the previous 9 years.
The Current Opinion in Endocrinology, Diabetes and Obesity has an SJR (SCImago Journal Rank) of 0.746, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.467 in 2017 and the lowest being 0.746 in 2022. Furthermore, the average SJR of the Current Opinion in Endocrinology, Diabetes and Obesity over the previous 9-year period stands at 3.4.
The latest h-index of the Current Opinion in Endocrinology, Diabetes and Obesity is 78.
The Current Opinion in Endocrinology, Diabetes and Obesity is published by the Lippincott Williams and Wilkins Ltd., with its country of publication being the United States.
The Current Opinion in Endocrinology, Diabetes and Obesity is currently ranked 6551 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 2393 in 2017 and its lowest position of 6551 in 2022.
The standard ISO4 abbreviation for the Current Opinion in Endocrinology, Diabetes and Obesity is Curr. Opin. Endocrinol. Diabetes Obes..
Current Opinion in Endocrinology, Diabetes and Obesity is classified as a journal that the Lippincott Williams and Wilkins Ltd. publishes.
The Current Opinion in Endocrinology, Diabetes and Obesity encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Current Opinion in Endocrinology, Diabetes and Obesity is assigned the following International Standard Serial Numbers (ISSN): 1752296X, 17522978.
The best quartile for the Current Opinion in Endocrinology, Diabetes and Obesity is Q2 (2022).
The Current Opinion in Endocrinology, Diabetes and Obesity coverage history can be summarized as follows: 2007-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Indian Journal of Plastic Surgery | journal | 16018 | Thieme Medical Publishers Inc. | 37 | 0.65 |
| Historia | journal | 27560 | Universidade Estadual Paulista | 7 | 0.02 |
| Journal of Field Archaeology | journal | 5639 | Maney Publishing | 43 | 2.38 |
| IEEE/OSA Journal of Display Technology | journal | 12809 | IEEE Computer Society | 68 | 0.00 |
| Journal of Competition Law and Economics | journal | 14815 | Oxford University Press | 29 | 0.72 |
| Journal of Applied Business Research | journal | 23890 | 29 | 0.28 | |
| Discourse | journal | 6621 | Routledge | 59 | 2.11 |
| Studies in Continuing Education | journal | 6011 | Routledge | 38 | 2.81 |
| Tekstilec | trade journal | 19217 | Faculty of Natural Sciences and Engineering, Tekstilec | 14 | 0.73 |
| Built Environment | journal | 12797 | Alexandrine Press | 43 | 1.15 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.84 |
| 2021 | 3.18 |
| 2020 | 2.75 |
| 2019 | 3.59 |
| 2018 | 3.42 |
| 2017 | 3.56 |
| 2016 | 4.15 |
| 2015 | 3.53 |
| 2014 | 3.55 |
